ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 19 filers reported holding ARCA BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $303,000 | +11.8% | 811,227 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $271,000 | -40.3% | 811,227 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $454,000 | +0.7% | 811,227 | 0.0% | 0.02% | -5.9% |
| Q2 2018 | $451,000 | +11.4% | 811,227 | 0.0% | 0.02% | +6.2% |
| Q1 2018 | $405,000 | -63.7% | 811,227 | 0.0% | 0.02% | -62.8% |
| Q4 2017 | $1,115,000 | +25.0% | 811,227 | 0.0% | 0.04% | +34.4% |
| Q3 2017 | $892,000 | -55.1% | 811,227 | 0.0% | 0.03% | -56.8% |
| Q2 2017 | $1,988,000 | -2.0% | 811,227 | 0.0% | 0.07% | -6.3% |
| Q1 2017 | $2,028,000 | -12.3% | 811,227 | 0.0% | 0.08% | -19.4% |
| Q4 2016 | $2,312,000 | -1.4% | 811,227 | 0.0% | 0.10% | +8.9% |
| Q3 2016 | $2,344,000 | -0.4% | 811,227 | 0.0% | 0.09% | -6.2% |
| Q2 2016 | $2,353,000 | -15.5% | 811,227 | 0.0% | 0.10% | -18.6% |
| Q1 2016 | $2,783,000 | -26.2% | 811,227 | 0.0% | 0.12% | -13.9% |
| Q4 2015 | $3,772,000 | -6.4% | 811,227 | 0.0% | 0.14% | -5.5% |
| Q3 2015 | $4,032,000 | – | 811,227 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $35,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $303,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 576 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,986 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,679 | $18,000 | 0.00% |
| MORGAN STANLEY | 2,000 | $1,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 219,236 | $82,000 | 0.00% |
| BlackRock Inc. | 865 | $0 | 0.00% |
| Citadel Advisors | 81,938 | $31,000 | 0.00% |